Balboa Pharmacy
Outcome
Balboa Pharmacy paid $105,000 and entered a DEA Memorandum of Agreement requiring new red-flag policies and training after the government alleged the pharmacy repeatedly dispensed high-dose opioids and dangerous drug combinations without resolving known red flags.
Details
Balboa Pharmacy — Opioid Red Flag Dispensing Violations (2022)
Outcome: Balboa Pharmacy paid $105,000 and entered a DEA Memorandum of Agreement requiring new red-flag policies and training after the government alleged the pharmacy repeatedly dispensed high-dose opioids and dangerous drug combinations without resolving known red flags.
Balboa Pharmacy, a San Diego, California pharmacy, was the subject of a DEA and DOJ investigation focused on its dispensing practices for opioids and other controlled substances. The investigation examined prescriptions filled by Balboa during a period spanning 2019 through 2021.
The United States alleged that Balboa Pharmacy failed to meet its responsibility as a pharmacist when it filled opioid prescriptions without resolving — or often even attempting to resolve — red flags that the prescriptions raised. The settlement agreement identified specific red flag categories that the pharmacy systematically ignored: large quantities of opioids exceeding a daily Morphine Milligram Equivalent of 100; dangerous combinations including duplicative therapy (opioids prescribed alongside benzodiazepines such as Valium and Xanax); the particularly dangerous combination of opioids, benzodiazepines, and muscle relaxants (e.g., Soma), colloquially known as the "trinity" for the rapid euphoric effects it produces; patients obtaining prescriptions from multiple prescribers for the same or dangerous combinations of controlled substances; and patients receiving prescription refills early — before their previous prescription for the same drug had been exhausted.
The civil settlement was announced on January 20, 2022, with Balboa Pharmacy paying $105,000. In addition to the monetary penalty, the DEA and Balboa Pharmacy entered into a Memorandum of Agreement in October 2021 requiring the pharmacy to develop and implement policies and procedures and training programs specifically addressing the identification and resolution of red flags prior to dispensing controlled substances.
Primary Source: San Diego Pharmacy Pays $105,000 Penalty for Illegitimately Dispensing Opioids — DOJ Southern District of California
How Crucible Prevents This
Crucible's prescription screening controls would have flagged the specific red flag categories cited in the settlement: daily MME thresholds above 100, opioid-benzodiazepine combinations, the opioid-benzodiazepine-muscle relaxant "trinity" combination, multi-prescriber patterns, and early refill requests. Mandatory documentation of red-flag resolution decisions — with supervisor escalation for overrides — would have created the accountability structure required by the subsequent DEA Memorandum of Agreement, building compliance into daily workflow rather than retrofitting it after enforcement action.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works